ETE Metrics

Tracking Progress to End the HIV Epidemic

The New York State Department of Health AIDS Institute uses 16 population-level metrics to help track progress towards Ending the Epidemic by the end of 2020. Select metrics from the list below to view annual outcomes  and ETE targets on the chart. Annual outcomes are viewable by sex, age group, and race/ethnicity for metrics where data are available. View more at ETE Data Directory.

metrics

Prevention And Testing (3)

PrEP Utilization
PrEP Utilization - Medicaid
HIV Status Aware

INCIDENCE AND NEW DIAGNOSES (5)

New HIV Infections (Incidence)
New HIV Diagnoses
Newly Diagnosed HIV - PWID
Concurrent AIDS Diagnoses
Linkage to Care

Retention And Care (7)

Receiving HIV Medical Care
Viral Suppression - Newly Diagnosed HIV
Viral Suppression - PLWDH
Viral Suppression - Receiving HIV Care
Sustained Viral Load Suppression
Time to AIDS Diagnosis
Stigma

DEATHS (1)

HIV Related Deaths

ETE: Bending the Curve (1)

ETE: Bending the Curve (NYS)

SELECT LOCATION

SELECT DEMOGRAPHIC

SHOW TARGETS & GOAL

ETE: Bending the Curve

Achieve fewer new HIV infections than deaths

2020 New HIV Infections 1,467 | 2020 Deaths among PLWDH 2,367

Chart notes:
  • Source: NYS HIV Surveillance System
  • Bending the curve metric displays HIV incidence minus all deaths among persons living with diagnosed HIV.

Explore data related to:

New HIV Infections (Incidence)

Significantly reduce the number of new HIV infections

2023 Actual 1,615

Chart notes:
  • Source: NYS HIV Surveillance System
  • An estimated number of people who have acquired HIV; diagnosed and undiagnosed.
  • Incidence and undiagnosed estimates are calculated using CDC methodology released in 2022.

Explore data related to:

PrEP Utilization

Increase the number of individuals filling prescriptions for PrEP to 65,000

2023 Actual 55,891 | Goal 65,000

Chart notes:
  • Source: IDV (Integrated Dataverse) from Symphony Health.
  • Number of individuals filling at least one prescription for Truvada or Descovy within the calendar year.
  • The FDA approved Descovy for PrEP on 10/3/2019.

Explore data related to:

PrEP Utilization - Medicaid

Increase the number of Medicaid recipients filling prescriptions for PrEP to 30,000

2023 Actual 13,514 | Goal 30,000

Chart notes:
  • Source: NYS Medicaid Data Warehouse.
  • Number of Medicaid recipients filling at least one prescription for Truvada or Descovy within the calendar year.
  • The FDA approved Descovy for PrEP on 10/3/2019.

Explore data related to:

HIV Status Aware

Increase the percentage of persons living with HIV who know their serostatus to at least 98%

2023 Actual 94% | Goal 98%

Chart notes:
  • Source: NYS HIV Surveillance System
  • An estimated percentage of people living with HIV who have been diagnosed.
  • Incidence and undiagnosed estimates are calculated using CDC methodology released in 2023.

Explore data related to:

New HIV Diagnoses

Reduce the number of new HIV diagnoses by 55% to 1,515

2023 Actual 2,517 | Goal 1,515

Chart notes:
  • Source: NYS HIV Surveillance System
  • Number of persons newly diagnosed with HIV.

Explore data related to:

Newly Diagnosed HIV – Persons with a History of Injection Drug Use

Reduce the percentage of persons newly diagnosed with HIV who indicate a history of injection drug use to 2.8%

2023 Actual 4.9% | Goal 2.8%

Chart notes:
  • Source: NYS HIV Surveillance System
  • Percent of persons newly diagnosed with HIV who indicate a history of injection drug use (IDU). Includes persons who indicate IDU and MSM/IDU history.

Explore data related to:

Concurrent AIDS Diagnoses

Reduce the percentage of persons with a diagnosis of AIDS within 30 days of HIV diagnosis to 15.0%

2023 Actual 19.4% | Goal 15.0%

Chart notes:
  • Source: NYS HIV Surveillance System
  • HIV infection with simultaneous AIDS diagnosis, or AIDS diagnosis (stage 3 HIV) within 30 days.

Explore data related to:

Linkage to Care

Increase the percentage of newly diagnosed persons linked to HIV medical care within 30 days of diagnosis to at least 90%

2023 Actual 79% | Goal 90%

Chart notes:
  • Source: NYS HIV Surveillance System
  • Newly diagnosed with any VL, CD4, or genotype within 30 days of diagnosis by diagnosis year.

Explore data related to:

Receiving HIV Medical Care

Increase the percentage of persons living with diagnosed HIV (PLWDH) who receive HIV medical care to 90%

2023 Actual 89% | Goal 90%

Chart notes:
  • Source: NYS HIV Surveillance System
  • Any VL, CD4, or genotype test in a calendar year.

Explore data related to:

Viral Load Suppression – Newly Diagnosed HIV

Increase the percentage of persons newly diagnosed with HIV who reach viral load suppression within 3 months of diagnosis to 75%

2023 Actual 58% | Goal 75%

Chart notes:
  • Source: NYS HIV Surveillance System
  • Viral load test suppressed (non-detectable or <200 copies/mL) within 91 days from the date of HIV diagnosis.

Explore data related to:

Viral Load Suppression - PLWDH

Increase the percentage of PLWDH with suppressed viral load to 85%

2023 Actual 80% | Goal 85%

Chart notes:
  • Source: NYS HIV Surveillance System
  • Last viral load test in calendar year is non-detectable or <200 copies/mL.

Explore data related to:

Viral Load Suppression - Receiving HIV Medical Care

Increase the percentage of PLWDH who receive HIV medical care with suppressed viral load to 95%

2023 Actual 90% | Goal 95%

Chart notes:
  • Source: NYS HIV Surveillance System
  • Last viral load test in calendar year is non-detectable or <200 copies/mL, among those in care during the calendar year.

Explore data related to:

Sustained Viral Load Suppression

Increase the percentage of PLWDH with sustained viral load suppression to 75%

2023 Actual 72% | Goal 75%

Chart notes:
  • Source: NYS HIV Surveillance System
  • Viral load test suppressed (non-detectable or <200 copies/mL) on all viral load tests in the previous 2 years, among those with at least 2 viral load tests in the previous 2 years.

Explore data related to:

Time to AIDS Diagnosis

Reduce the rate at which persons newly diagnosed with HIV progress to AIDS by 50%

2021 Actual 4.3% | Goal 5.1%

Chart notes:
  • Source: NYS HIV Surveillance System
  • AIDS diagnosis within 2 years of HIV diagnosis.

Explore data related to:

Stigma

Decrease stigma experienced among PLWDH to at least 25%

2022 Actual 31% | Goal 25%

Chart notes:
  • Source: NYS Medical Monitoring Project.
  • Based on the results of a 10 question scale looking at 4 dimensions of stigma (personalized stigma, disclosure concerns, negative self-image, and perceived public attitudes about people with HIV).

HIV Related Deaths

Reduce the percentage of deaths directly related to HIV to 20%

2022 Actual 18% | Goal 20%

Chart notes:
  • Source: NYS HIV Surveillance System
  • The percentage of deaths that were related to HIV among persons with diagnosed HIV. Primary cause of death was used for HIV death ascertainment.

Explore data related to:

ETE Metrics Notes

  • Data as of June 2021.
  • Data sources for NYS Statewide and NYC data are the NYS HIV Surveillance System and the NYC DOHMH Surveillance System, respectively, unless otherwise noted below each chart.
  • NYS Statewide 2020 ETE targets are displayed in all instances, except for the NYC-specific ETE 2020 goals for New HIV Infections (660) and New HIV Diagnoses (1,350) when New York City is selected.
  • NYS Statewide data is viewable by sex, age, or race/ethnicity, and NYC data is viewable by race/ethnicity for select metrics. No stratifications are available for Bending the Curve, Stigma, or HIV Status Aware. No race/ethnicity or age data are shown for either PrEP Utilization metric.
  • Proportions for some metrics filtered by age or race/ethnicity (e.g. Native American) are unstable due to low numbers; data are either hidden or should be interpreted with caution.

Click here to view all 16 ETE metrics simultaneously

DESIGNED AND DEVELOPED BY:
CUNY Institute for Implementation Science in Population Health
FUNDED BY:
New York State Department of Health
CONNECT WITH US:
For general inquiries:

info@etedashboardny.org